DJIA 18,041.54 -190.48 -1.04%
NASDAQ 5,032.75 -56.61 -1.11%
S&P 500 2,104.20 -21.86 -1.03%
market minute promo

EXACT Sciences Corp (NASDAQ: EXAS)

26.55 0.35 (1.34%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

EXAS $26.55 1.34%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $26.18
Previous Close $26.20
Daily Range $26.00 - $26.64
52-Week Range $13.02 - $29.97
Market Cap $2.4B
P/E Ratio -18.45
Dividend (Yield) $0.00 (0.0%)
Volume 1,263,367
Average Daily Volume 1,602,400
Current FY EPS -$1.75




Drug Makers

EXACT Sciences Corp (EXAS) Description

An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer. Website:

News & Commentary

3 Ways Personalized Medicine Could Completely Transform Your Life

The one-size-fits-all doctor-patient relationship that's existed for decades is slowly dying. Instead, an array of new personalized interactions, along with diagnostics, devices, and therapies, are taking its place.

Exact (EXAS) Marked As A Dead Cat Bounce Stock

Exact (EXAS) Flagged As Strong On High Volume

Exact Sciences' Significant Upside Looks Reasonably Priced

How To Manage The Risks To Investing In The Aging Population

Commit To Buy EXACT Sciences Corp. At $15, Earn 14.3% Using Options

Trade-Ideas: Exact (EXAS) Is Today's Strong On High Relative Volume Stock

3 Tiny Healthcare Stocks You Ought to Be Watching

Celldex Therapeutics, Inc., Exact Sciences Corporation, and Sangamo Biosciences could all have market moving news this year.

Exact (EXAS) Weak On High Volume Today

CNBC's Stock Pops & Drops From May 4

See More EXAS News...

EXAS's Top Competitors

EXAS $26.55 (1.34%)
Current stock: EXAS
AMGN $159.01 (-2.79%)
Current stock: AMGN
GILD $109.77 (-1.74%)
Current stock: GILD
BIIB $392.88 (-1.45%)
Current stock: BIIB